0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-LVP Parenterals Products Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-23P2721
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Non LVP Parenterals Products Market Insights and Forecast to 2028
BUY CHAPTERS

Global Non-LVP Parenterals Products Market Research Report 2024

Code: QYRE-Auto-23P2721
Report
January 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-LVP Parenterals Products Market

Non-LVP parenterals products referred to the small volume parenteral except biologicals. Small volume parenteral solutions are usually 100 ml or less and are packaged in different ways depending on the intended use. If the SVP is a liquid that is used primarily to deliver medications, it is packaged in a small plastic bag called a minibag of 50 - 100 ml (minibags look like small plastic LVP bags). SVPs can also be packaged as ampules, vials, and prefilled syringes. Liquid drugs are supplied in prefilled syringes, heat-sealed ampules, or in vials sealed with a rubber closure. Powdered drugs are supplied in vials and must be constituted (dissolved in a suitable liquid) before being added to any solution. SVPs packaged as ampules, vials, or prefilled syringes are typically added to a minibag or a LVP but they may also serve as the final container. The term admixture is used to denote a solution where such an additive has been added to a minibag or LVP.
The global Non-LVP Parenterals Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Non-LVP Parenterals Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-LVP Parenterals Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-LVP Parenterals Products include Allergan, Bayer, GSK, J&J, Pfizer, Teva and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-LVP Parenterals Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-LVP Parenterals Products.

Report Scope

The Non-LVP Parenterals Products market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-LVP Parenterals Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-LVP Parenterals Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Non-LVP Parenterals Products Market Report

Report Metric Details
Report Name Non-LVP Parenterals Products Market
Segment by Type
  • Ampules
  • Vials
  • Prefilled Syringes
Segment by Application
  • Local Anesthetics
  • Vaccines
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, Bayer, GSK, J&J, Pfizer, Teva, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-LVP Parenterals Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-LVP Parenterals Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-LVP Parenterals Products Market report?

Ans: The main players in the Non-LVP Parenterals Products Market are Allergan, Bayer, GSK, J&J, Pfizer, Teva, Novartis

What are the Application segmentation covered in the Non-LVP Parenterals Products Market report?

Ans: The Applications covered in the Non-LVP Parenterals Products Market report are Local Anesthetics, Vaccines, Other

What are the Type segmentation covered in the Non-LVP Parenterals Products Market report?

Ans: The Types covered in the Non-LVP Parenterals Products Market report are Ampules, Vials, Prefilled Syringes

1 Non-LVP Parenterals Products Market Overview
1.1 Product Overview and Scope of Non-LVP Parenterals Products
1.2 Non-LVP Parenterals Products Segment by Type
1.2.1 Global Non-LVP Parenterals Products Market Value Comparison by Type (2024-2030)
1.2.2 Ampules
1.2.3 Vials
1.2.4 Prefilled Syringes
1.3 Non-LVP Parenterals Products Segment by Application
1.3.1 Global Non-LVP Parenterals Products Market Value by Application: (2024-2030)
1.3.2 Local Anesthetics
1.3.3 Vaccines
1.3.4 Other
1.4 Global Non-LVP Parenterals Products Market Size Estimates and Forecasts
1.4.1 Global Non-LVP Parenterals Products Revenue 2019-2030
1.4.2 Global Non-LVP Parenterals Products Sales 2019-2030
1.4.3 Global Non-LVP Parenterals Products Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-LVP Parenterals Products Market Competition by Manufacturers
2.1 Global Non-LVP Parenterals Products Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-LVP Parenterals Products Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-LVP Parenterals Products Average Price by Manufacturers (2019-2024)
2.4 Global Non-LVP Parenterals Products Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-LVP Parenterals Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-LVP Parenterals Products, Product Type & Application
2.7 Non-LVP Parenterals Products Market Competitive Situation and Trends
2.7.1 Non-LVP Parenterals Products Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-LVP Parenterals Products Players Market Share by Revenue
2.7.3 Global Non-LVP Parenterals Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-LVP Parenterals Products Retrospective Market Scenario by Region
3.1 Global Non-LVP Parenterals Products Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-LVP Parenterals Products Global Non-LVP Parenterals Products Sales by Region: 2019-2030
3.2.1 Global Non-LVP Parenterals Products Sales by Region: 2019-2024
3.2.2 Global Non-LVP Parenterals Products Sales by Region: 2025-2030
3.3 Global Non-LVP Parenterals Products Global Non-LVP Parenterals Products Revenue by Region: 2019-2030
3.3.1 Global Non-LVP Parenterals Products Revenue by Region: 2019-2024
3.3.2 Global Non-LVP Parenterals Products Revenue by Region: 2025-2030
3.4 North America Non-LVP Parenterals Products Market Facts & Figures by Country
3.4.1 North America Non-LVP Parenterals Products Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-LVP Parenterals Products Sales by Country (2019-2030)
3.4.3 North America Non-LVP Parenterals Products Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-LVP Parenterals Products Market Facts & Figures by Country
3.5.1 Europe Non-LVP Parenterals Products Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-LVP Parenterals Products Sales by Country (2019-2030)
3.5.3 Europe Non-LVP Parenterals Products Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-LVP Parenterals Products Market Facts & Figures by Country
3.6.1 Asia Pacific Non-LVP Parenterals Products Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-LVP Parenterals Products Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-LVP Parenterals Products Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-LVP Parenterals Products Market Facts & Figures by Country
3.7.1 Latin America Non-LVP Parenterals Products Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-LVP Parenterals Products Sales by Country (2019-2030)
3.7.3 Latin America Non-LVP Parenterals Products Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-LVP Parenterals Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-LVP Parenterals Products Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-LVP Parenterals Products Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-LVP Parenterals Products Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-LVP Parenterals Products Sales by Type (2019-2030)
4.1.1 Global Non-LVP Parenterals Products Sales by Type (2019-2024)
4.1.2 Global Non-LVP Parenterals Products Sales by Type (2025-2030)
4.1.3 Global Non-LVP Parenterals Products Sales Market Share by Type (2019-2030)
4.2 Global Non-LVP Parenterals Products Revenue by Type (2019-2030)
4.2.1 Global Non-LVP Parenterals Products Revenue by Type (2019-2024)
4.2.2 Global Non-LVP Parenterals Products Revenue by Type (2025-2030)
4.2.3 Global Non-LVP Parenterals Products Revenue Market Share by Type (2019-2030)
4.3 Global Non-LVP Parenterals Products Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-LVP Parenterals Products Sales by Application (2019-2030)
5.1.1 Global Non-LVP Parenterals Products Sales by Application (2019-2024)
5.1.2 Global Non-LVP Parenterals Products Sales by Application (2025-2030)
5.1.3 Global Non-LVP Parenterals Products Sales Market Share by Application (2019-2030)
5.2 Global Non-LVP Parenterals Products Revenue by Application (2019-2030)
5.2.1 Global Non-LVP Parenterals Products Revenue by Application (2019-2024)
5.2.2 Global Non-LVP Parenterals Products Revenue by Application (2025-2030)
5.2.3 Global Non-LVP Parenterals Products Revenue Market Share by Application (2019-2030)
5.3 Global Non-LVP Parenterals Products Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Non-LVP Parenterals Products Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Non-LVP Parenterals Products Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Non-LVP Parenterals Products Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 J&J
6.4.1 J&J Corporation Information
6.4.2 J&J Description and Business Overview
6.4.3 J&J Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 J&J Non-LVP Parenterals Products Product Portfolio
6.4.5 J&J Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Non-LVP Parenterals Products Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Non-LVP Parenterals Products Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Non-LVP Parenterals Products Product Portfolio
6.7.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-LVP Parenterals Products Industry Chain Analysis
7.2 Non-LVP Parenterals Products Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-LVP Parenterals Products Production Mode & Process
7.4 Non-LVP Parenterals Products Sales and Marketing
7.4.1 Non-LVP Parenterals Products Sales Channels
7.4.2 Non-LVP Parenterals Products Distributors
7.5 Non-LVP Parenterals Products Customers
8 Non-LVP Parenterals Products Market Dynamics
8.1 Non-LVP Parenterals Products Industry Trends
8.2 Non-LVP Parenterals Products Market Drivers
8.3 Non-LVP Parenterals Products Market Challenges
8.4 Non-LVP Parenterals Products Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Non-LVP Parenterals Products Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Non-LVP Parenterals Products Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Non-LVP Parenterals Products Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Non-LVP Parenterals Products Sales (K Doses) of Key Manufacturers (2019-2024)
    Table 5. Global Non-LVP Parenterals Products Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Non-LVP Parenterals Products Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Non-LVP Parenterals Products Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Non-LVP Parenterals Products Average Price (USD/Dose) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Non-LVP Parenterals Products, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Non-LVP Parenterals Products, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Non-LVP Parenterals Products, Product Type & Application
    Table 12. Global Key Manufacturers of Non-LVP Parenterals Products, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Non-LVP Parenterals Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-LVP Parenterals Products as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Non-LVP Parenterals Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Non-LVP Parenterals Products Sales by Region (2019-2024) & (K Doses)
    Table 18. Global Non-LVP Parenterals Products Sales Market Share by Region (2019-2024)
    Table 19. Global Non-LVP Parenterals Products Sales by Region (2025-2030) & (K Doses)
    Table 20. Global Non-LVP Parenterals Products Sales Market Share by Region (2025-2030)
    Table 21. Global Non-LVP Parenterals Products Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Non-LVP Parenterals Products Revenue Market Share by Region (2019-2024)
    Table 23. Global Non-LVP Parenterals Products Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Non-LVP Parenterals Products Revenue Market Share by Region (2025-2030)
    Table 25. North America Non-LVP Parenterals Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Non-LVP Parenterals Products Sales by Country (2019-2024) & (K Doses)
    Table 27. North America Non-LVP Parenterals Products Sales by Country (2025-2030) & (K Doses)
    Table 28. North America Non-LVP Parenterals Products Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Non-LVP Parenterals Products Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Non-LVP Parenterals Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Non-LVP Parenterals Products Sales by Country (2019-2024) & (K Doses)
    Table 32. Europe Non-LVP Parenterals Products Sales by Country (2025-2030) & (K Doses)
    Table 33. Europe Non-LVP Parenterals Products Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Non-LVP Parenterals Products Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Non-LVP Parenterals Products Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Non-LVP Parenterals Products Sales by Region (2019-2024) & (K Doses)
    Table 37. Asia Pacific Non-LVP Parenterals Products Sales by Region (2025-2030) & (K Doses)
    Table 38. Asia Pacific Non-LVP Parenterals Products Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Non-LVP Parenterals Products Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Non-LVP Parenterals Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Non-LVP Parenterals Products Sales by Country (2019-2024) & (K Doses)
    Table 42. Latin America Non-LVP Parenterals Products Sales by Country (2025-2030) & (K Doses)
    Table 43. Latin America Non-LVP Parenterals Products Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Non-LVP Parenterals Products Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Non-LVP Parenterals Products Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Non-LVP Parenterals Products Sales by Country (2019-2024) & (K Doses)
    Table 47. Middle East & Africa Non-LVP Parenterals Products Sales by Country (2025-2030) & (K Doses)
    Table 48. Middle East & Africa Non-LVP Parenterals Products Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Non-LVP Parenterals Products Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Non-LVP Parenterals Products Sales (K Doses) by Type (2019-2024)
    Table 51. Global Non-LVP Parenterals Products Sales (K Doses) by Type (2025-2030)
    Table 52. Global Non-LVP Parenterals Products Sales Market Share by Type (2019-2024)
    Table 53. Global Non-LVP Parenterals Products Sales Market Share by Type (2025-2030)
    Table 54. Global Non-LVP Parenterals Products Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Non-LVP Parenterals Products Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Non-LVP Parenterals Products Revenue Market Share by Type (2019-2024)
    Table 57. Global Non-LVP Parenterals Products Revenue Market Share by Type (2025-2030)
    Table 58. Global Non-LVP Parenterals Products Price (USD/Dose) by Type (2019-2024)
    Table 59. Global Non-LVP Parenterals Products Price (USD/Dose) by Type (2025-2030)
    Table 60. Global Non-LVP Parenterals Products Sales (K Doses) by Application (2019-2024)
    Table 61. Global Non-LVP Parenterals Products Sales (K Doses) by Application (2025-2030)
    Table 62. Global Non-LVP Parenterals Products Sales Market Share by Application (2019-2024)
    Table 63. Global Non-LVP Parenterals Products Sales Market Share by Application (2025-2030)
    Table 64. Global Non-LVP Parenterals Products Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Non-LVP Parenterals Products Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Non-LVP Parenterals Products Revenue Market Share by Application (2019-2024)
    Table 67. Global Non-LVP Parenterals Products Revenue Market Share by Application (2025-2030)
    Table 68. Global Non-LVP Parenterals Products Price (USD/Dose) by Application (2019-2024)
    Table 69. Global Non-LVP Parenterals Products Price (USD/Dose) by Application (2025-2030)
    Table 70. Allergan Corporation Information
    Table 71. Allergan Description and Business Overview
    Table 72. Allergan Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 73. Allergan Non-LVP Parenterals Products Product
    Table 74. Allergan Recent Developments/Updates
    Table 75. Bayer Corporation Information
    Table 76. Bayer Description and Business Overview
    Table 77. Bayer Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 78. Bayer Non-LVP Parenterals Products Product
    Table 79. Bayer Recent Developments/Updates
    Table 80. GSK Corporation Information
    Table 81. GSK Description and Business Overview
    Table 82. GSK Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 83. GSK Non-LVP Parenterals Products Product
    Table 84. GSK Recent Developments/Updates
    Table 85. J&J Corporation Information
    Table 86. J&J Description and Business Overview
    Table 87. J&J Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 88. J&J Non-LVP Parenterals Products Product
    Table 89. J&J Recent Developments/Updates
    Table 90. Pfizer Corporation Information
    Table 91. Pfizer Description and Business Overview
    Table 92. Pfizer Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 93. Pfizer Non-LVP Parenterals Products Product
    Table 94. Pfizer Recent Developments/Updates
    Table 95. Teva Corporation Information
    Table 96. Teva Description and Business Overview
    Table 97. Teva Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 98. Teva Non-LVP Parenterals Products Product
    Table 99. Teva Recent Developments/Updates
    Table 100. Novartis Corporation Information
    Table 101. Novartis Description and Business Overview
    Table 102. Novartis Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 103. Novartis Non-LVP Parenterals Products Product
    Table 104. Novartis Recent Developments/Updates
    Table 105. Key Raw Materials Lists
    Table 106. Raw Materials Key Suppliers Lists
    Table 107. Non-LVP Parenterals Products Distributors List
    Table 108. Non-LVP Parenterals Products Customers List
    Table 109. Non-LVP Parenterals Products Market Trends
    Table 110. Non-LVP Parenterals Products Market Drivers
    Table 111. Non-LVP Parenterals Products Market Challenges
    Table 112. Non-LVP Parenterals Products Market Restraints
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Non-LVP Parenterals Products
    Figure 2. Global Non-LVP Parenterals Products Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Non-LVP Parenterals Products Market Share by Type in 2023 & 2030
    Figure 4. Ampules Product Picture
    Figure 5. Vials Product Picture
    Figure 6. Prefilled Syringes Product Picture
    Figure 7. Global Non-LVP Parenterals Products Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Non-LVP Parenterals Products Market Share by Application in 2023 & 2030
    Figure 9. Local Anesthetics
    Figure 10. Vaccines
    Figure 11. Other
    Figure 12. Global Non-LVP Parenterals Products Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Non-LVP Parenterals Products Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Non-LVP Parenterals Products Sales (2019-2030) & (K Doses)
    Figure 15. Global Non-LVP Parenterals Products Average Price (USD/Dose) & (2019-2030)
    Figure 16. Non-LVP Parenterals Products Report Years Considered
    Figure 17. Non-LVP Parenterals Products Sales Share by Manufacturers in 2023
    Figure 18. Global Non-LVP Parenterals Products Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Non-LVP Parenterals Products Players: Market Share by Revenue in 2023
    Figure 20. Non-LVP Parenterals Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Non-LVP Parenterals Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Non-LVP Parenterals Products Sales Market Share by Country (2019-2030)
    Figure 23. North America Non-LVP Parenterals Products Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Non-LVP Parenterals Products Sales Market Share by Country (2019-2030)
    Figure 27. Europe Non-LVP Parenterals Products Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Non-LVP Parenterals Products Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Non-LVP Parenterals Products Revenue Market Share by Region (2019-2030)
    Figure 35. China Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Taiwan Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Philippines Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Non-LVP Parenterals Products Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Non-LVP Parenterals Products Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Non-LVP Parenterals Products Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Non-LVP Parenterals Products Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. U.A.E Non-LVP Parenterals Products Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Non-LVP Parenterals Products by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Non-LVP Parenterals Products by Type (2019-2030)
    Figure 57. Global Non-LVP Parenterals Products Price (USD/Dose) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Non-LVP Parenterals Products by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Non-LVP Parenterals Products by Application (2019-2030)
    Figure 60. Global Non-LVP Parenterals Products Price (USD/Dose) by Application (2019-2030)
    Figure 61. Non-LVP Parenterals Products Value Chain
    Figure 62. Non-LVP Parenterals Products Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Zanthoxylum Bungeanum Extract - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-36S14110
Thu May 02 00:00:00 UTC 2024

Add to Cart

High Capacity Endotoxin Removal Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14G14630
Thu May 02 00:00:00 UTC 2024

Add to Cart

Rapid Endotoxin Removal Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-7R14828
Thu May 02 00:00:00 UTC 2024

Add to Cart

Automated Complete Blood Cell Counter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38S14317
Thu May 02 00:00:00 UTC 2024

Add to Cart